Occudo Quantitative Strategies’s Medifast MED Stock Holding History

Occudo Quantitative Strategies’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-12,167	Closed	-$233K	–	833
2024 Q3	$233K	Sell	12,167 -20,065	-62%	-$387K	0.04%	541
2024 Q2	$703K	Buy	32,232 +8,239	+34%	+$220K	0.12%	234
2024 Q1	$919K	Buy	+23,993	New	+$1.16M	0.16%	181
2023 Q4	–	Sell	-12,125	Closed	-$908K	–	1040
2023 Q3	$908K	Buy	12,125 +2,048	+20%	+$182K	0.12%	295
2023 Q2	$929K	Sell	10,077 -3,207	-24%	-$286K	0.1%	359
2023 Q1	$1.38M	Buy	+13,284	New	+$1.47M	0.12%	231

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Hotchkis & Wiley Capital Management

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Federated Hermes

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return